Work place and prevalence of COVID-19 in a rural population in Greece.


Journal

Rural and remote health
ISSN: 1445-6354
Titre abrégé: Rural Remote Health
Pays: Australia
ID NLM: 101174860

Informations de publication

Date de publication:
07 2022
Historique:
entrez: 19 7 2022
pubmed: 20 7 2022
medline: 22 7 2022
Statut: ppublish

Résumé

Coronavirus disease-19 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic, giving rise to a serious global health threat. Many countries including Greece have seen a two-wave pattern of reported cases, with a first wave in spring and a second in autumn of 2020. A cross-sectional seroprevalence study was designed to measure the prevalence of IgG antibodies with a quantitative SARS-CoV-2 IgG lab-based serology test, chemiluminescent microparticle immunoassay, against novel coronavirus in rural areas in Greece after the second pandemic wave. The study was conducted on 29 January 2021 in a rural semi-closed area, the municipality of Deskati, prefecture of western Macedonia in Greece after the second pandemic wave. Sixty-nine participants were included in this study. The present study demonstrated a high prevalence of COVID-19 infection (31 of 69 total participants; 45%) and those who were working in the public sector were at higher risk of COVID-19 infection in comparison to their counterparts in private sector (p=0.05364), (relative risk 2.64; 95% confidence interval 1.001-7.086). The study presents data showing a high prevalence of herd immunity for COVID-19 in a semi-closed area in Greece. These findings might help to understand the characteristics of this second wave, the behaviour and danger of SARS-CoV-2 in rural areas in Greece and Europe generally.

Identifiants

pubmed: 35853536
pii: 6751
doi: 10.22605/RRH6751
doi:

Substances chimiques

Immunoglobulin G 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6751

Auteurs

Dimitrios Papagiannis (D)

Public Health & Vaccines Laboratory, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa 41500, Greece dpapajon@gmail.com.

Ourania S Kotsiou (OS)

Public Health & Vaccines Laboratory, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa 41500, Greece okotsiou@uth.gr.

Evangelos C Fradelos (EC)

Public Health & Vaccines Laboratory, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa 41500, Greece evagelosfradelos@hotmail.com.

Garyfallia Perlepe (G)

Public Health & Vaccines Laboratory, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa 41500, Greece perlepef19@gmail.com.

Angeliki Miziou (A)

Public Health & Vaccines Laboratory, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa 41500, Greece kellymiz95@yahoo.com.

Dimitra S Siachpazidou (DS)

Public Health & Vaccines Laboratory, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa 41500, Greece sidimi@windowslive.com.

Konstantinos I Gourgoulianis (KI)

Public Health & Vaccines Laboratory, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa 41500, Greece kgourg@uth.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH